Tyrosine Hydroxylase (Ab-31) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Tyrosine Hydroxylase (Ab-31) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Tyrosine Hydroxylase (Ab-31) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | mouse, rat |
| Isotype | n/a |
| Format | epitope affinity purified |
| Size | 0.05 mL, 0.1 mL |
| Concentration | 1.0 mg/ml |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The antibody detects endogenous levels of total Tyrosine Hydroxylase protein. Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the synthesis of the neurotransmitter dopamine and other catecholamines. TH functions as a tetramer, with each subunit composed of a regulatory and catalytic domain, and exists in several different isoforms. This enzyme is required for embryonic development since TH knockout mice die before or at birth. Levels of transcription, translation and posttranslational modification regulate TH activity. The amino-terminal regulatory domain contains three serine residues: Ser9, Ser31 and Ser40. Phosphorylation at Ser40 by PKA positively regulates the catalytic activity of TH. Phosphorylation at Ser31 by CDK5 als |
| Immunogen | Immunogen Type: Peptide-KLH Immunogen Description: Peptide sequence around aa.29~33(V-T-S-P-R)derived from Mouse Tyrosine Hydroxylase. |
| Other Names | [TYH; DYT14; DYT5b; TH] |
| Gene, Accession # | Gene ID: 7054, NCBI: NP_000351.2, UniProt: P07101 |
| Catalog # | MBS9408999 |
| Price | $200, $255 |
| Order / More Info | Tyrosine Hydroxylase (Ab-31) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies